Alnylam Pharmaceuticals
ALNY
#656
Rank
A$55.45 B
Marketcap
A$415.34
Share price
3.60%
Change (1 day)
-16.71%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company